AKT1 and urinary bladder carcinoma: Several lines of evidence have suggested that early responsive regulators such as the MAPKs (ERK, JNK, and p38) and PI3K-AKT participate in the progression of bladder cancer (Dangle et al., 2009[6]; Gerhardt et al., 2014[9]).